US stock results analysis for Industry - Biotech for the month ending Sep 30, 2025
Analysis of which US stocks have performed the best and worst in Industry - Biotech for the month ending Sep 30, 2025 on the basis of sales/revenues, profits and profit margins. Only companies which have declared results in the current month are considered.
5
POSITIVE PROFIT GROWTH
8
NEGATIVE PROFIT GROWTH
1
NEUTRAL PROFIT GROWTH
3.6
%
TOTAL REVENUE GROWTH
558.8
%
TOTAL EBIDT GROWTH
0.8
%
TOTAL OPER. PROFIT GROWTH
Positive
Negative
Pending
| Stock | Last Result Updated | Market Capitalization | Current Price | Operating Revenue Qtr | Revenue Growth Qtr YoY % | Revenue Surprise Qtr % | Net Profit Qtr | Net Profit Qtr Growth YoY % | Net Profit Surprise Qtr % | Operating Profit Qtr | Operating Profit Growth Qtr YoY % | EBITDA Qtr | EBITDA Qtr growth YoY % | Operating Profit Margin Qtr % | Operating Profit Qtr Margin% YoY Change |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arcus Biosciences Inc | 28-Oct-2025 |
2129.24
|
19.72
|
26.00
|
-45.83
|
28.40
|
-135.00
|
-46.74
|
5.28
|
-142.00
|
-35.24
|
3.00
|
200.00
|
-
|
-
|
| Anixa Biosciences Inc | 10-Sep-2025 |
135.95
|
4.13
|
0.00
|
-
|
-
|
-2.26
|
31.10
|
-
|
-2.44
|
32.18
|
0.00
|
-
|
-
|
-
|
| AquaBounty Technologies Inc | 28-Oct-2025 |
5.04
|
1.30
|
0.00
|
-
|
-
|
-1.38
|
59.44
|
-
|
-1.41
|
12.63
|
0.00
|
-
|
-
|
-
|
| BridgeBio Pharma Inc | 29-Oct-2025 |
12071.28
|
62.64
|
120.70
|
4318.01
|
13.81
|
-182.74
|
-12.78
|
-4.36
|
-136.36
|
27.13
|
46.60
|
102.09
|
-
|
-
|
| BriaCell Therapeutics Corp | 16-Oct-2025 |
20.72
|
11.00
|
0.00
|
-
|
-
|
-8.09
|
-566.41
|
-
|
-8.55
|
-48.31
|
0.00
|
-
|
-
|
-
|
| Biogen | 30-Oct-2025 |
22631.76
|
154.27
|
2534.70
|
2.79
|
8.20
|
466.50
|
20.08
|
2.26
|
606.50
|
15.99
|
158.20
|
29.35
|
-
|
-
|
| Biomarin Pharmaceutical Inc | 28-Oct-2025 |
10291.57
|
53.57
|
776.13
|
4.08
|
-0.55
|
-30.74
|
-128.98
|
-173.05
|
-46.68
|
-140.99
|
7.00
|
-77.66
|
-
|
-
|
| Champions Oncology Inc | 15-Sep-2025 |
94.31
|
6.84
|
14.00
|
-0.47
|
3.63
|
-0.47
|
-135.49
|
-
|
-0.51
|
-138.15
|
0.01
|
-33.33
|
-3.62
|
-13.07
|
| Gilead Sciences | 30-Oct-2025 |
148898.97
|
119.79
|
7769.00
|
2.97
|
4.16
|
3052.00
|
143.58
|
45.49
|
3497.00
|
11.26
|
845.00
|
1532.20
|
45.01
|
3.36
|
| Illumina Inc | 31-Oct-2025 |
18988.10
|
123.54
|
1084.00
|
0.37
|
1.76
|
150.00
|
-78.72
|
-6.43
|
227.00
|
-10.28
|
95.00
|
86.27
|
-
|
-
|
| Merus NV | 31-Oct-2025 |
7188.91
|
94.86
|
12.15
|
3.21
|
39.98
|
-95.52
|
4.39
|
4.30
|
-96.48
|
-33.57
|
5.82
|
95.36
|
-
|
-
|
| Nautilus Biotechnology Inc | 28-Oct-2025 |
167.99
|
1.33
|
0.00
|
-
|
-
|
-13.57
|
17.46
|
-
|
-15.47
|
18.99
|
0.00
|
-
|
-
|
-
|
| Nuvalent Inc Ordinary Shares | 30-Oct-2025 |
7221.23
|
99.32
|
0.00
|
-
|
-
|
-122.44
|
-45.16
|
-
|
-112.70
|
-47.64
|
0.13
|
230.00
|
-
|
-
|
| Summit Therapeutics Inc | 20-Oct-2025 |
14077.41
|
18.91
|
0.00
|
-
|
-
|
-231.79
|
-312.05
|
-
|
-234.21
|
-301.20
|
0.00
|
-
|
-
|
-
|
